Home/CureGenetics/Dr. Yanni Lin
DY

Dr. Yanni Lin

Co-founder & Chief Scientist

CureGenetics

Therapeutic Areas

CureGenetics Pipeline

DrugIndicationPhase
CGC729Relapsed/Refractory Metastatic Clear Cell Renal Cell CarcinomaPhase 1